Review




Structured Review

Promega luciferase reporter plasmids prl-sv40
Luciferase Reporter Plasmids Prl Sv40, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase reporter plasmids prl-sv40/product/Promega
Average 90 stars, based on 1 article reviews
luciferase reporter plasmids prl-sv40 - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
Promega luciferase reporter plasmids prl-sv40
Luciferase Reporter Plasmids Prl Sv40, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/luciferase reporter plasmids prl-sv40/product/Promega
Average 90 stars, based on 1 article reviews
luciferase reporter plasmids prl-sv40 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega prl sv40 plasmid
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Prl Sv40 Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prl sv40 plasmid/product/Promega
Average 90 stars, based on 1 article reviews
prl sv40 plasmid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega prl-sv40
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Prl Sv40, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prl-sv40/product/Promega
Average 90 stars, based on 1 article reviews
prl-sv40 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega prl-sv40 renilla luciferase plasmid
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Prl Sv40 Renilla Luciferase Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prl-sv40 renilla luciferase plasmid/product/Promega
Average 90 stars, based on 1 article reviews
prl-sv40 renilla luciferase plasmid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Beyotime reporter gene plasmids pgl6-ta and prl-sv40-c
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Reporter Gene Plasmids Pgl6 Ta And Prl Sv40 C, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reporter gene plasmids pgl6-ta and prl-sv40-c/product/Beyotime
Average 90 stars, based on 1 article reviews
reporter gene plasmids pgl6-ta and prl-sv40-c - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega plasmid expressing renilla luciferase prl-sv40
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Plasmid Expressing Renilla Luciferase Prl Sv40, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid expressing renilla luciferase prl-sv40/product/Promega
Average 90 stars, based on 1 article reviews
plasmid expressing renilla luciferase prl-sv40 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega prl-sv40 plasmids
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Prl Sv40 Plasmids, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prl-sv40 plasmids/product/Promega
Average 90 stars, based on 1 article reviews
prl-sv40 plasmids - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Promega prl-sv40 plasmid
A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the <t>luciferase</t> reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a <t>Renilla</t> Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).
Prl Sv40 Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/prl-sv40 plasmid/product/Promega
Average 90 stars, based on 1 article reviews
prl-sv40 plasmid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the luciferase reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a Renilla Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).

Journal: Cell Death Discovery

Article Title: The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma

doi: 10.1038/s41420-025-02601-x

Figure Lengend Snippet: A ChIP peak locations within the human EIF4EBP1 promoter, exon 1 and part of intron 1 (hg38; Chr8: 38,030,342 - 38,031,906) from ChIP-sequencing data for MYC (Encode consortium, Encyclopedia of DNA Elements at UCSC [ , ]) and an illustration of the luciferase reporter construct containing the EIF4EBP1 promoter, exon 1 and part of intron 1 (−192; +1372) coupled to Firefly luciferase, with the indicated binding sites of the transcription factor MYC. The three E boxes present in the promoter, and corresponding introduced mutations, are indicated. B , C HEK293-T cells were transfected with the (−192; +1372) EIF4EBP1 promoter reporter construct, together with 25 ng, 50 ng and 100 ng MYC ( B ) or the (−192; +1372) EIF4EBP1 promoter reporter constructs containing a mutation of each of the E boxes (as indicated in A ), together with 25 ng MYC ( C ). For ( B ) and ( C ), a Renilla Luciferase vector was used as an internal control and luciferase activities were detected using the Dual-Luciferase Reporter Assay. Firefly luciferase activity was normalized to Renilla luciferase activity and the ratio was normalized to the corresponding 0 ng ( B ) or control ( C ) condition. Data represent the mean of four ( B ) or three ( C ) independent replicates ± standard deviation (SD). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, **** p < 0.0001). A representative immunoblot analyzing expression of MYC is presented in ( B ). D , E Med8A ( D ) and HD-MB03 ( E ) MB cells were transiently transfected with negative control siRNAs (siCtrl), or two different siRNAs each targeting MYC (siMYC#1 and siMYC#2). Cells were re-transfected after 96 h with their corresponding siRNA and incubated for a total of 168 h. MRNA was harvested to determine the expression levels of EIF4EBP1 and MYC by qRT-PCR. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the negative control (siCtrl). Significance was calculated using an unpaired and two-tailed parametric t test (* p < 0.05, ** p < 0.01, **** p < 0.0001). F Med8A MB cells were transiently transfected with negative control (siCtrl) or a pool of four different siRNAs (see Table ) targeting MYC (siMYC). Cells were incubated 72 h and protein was harvested for immunoblotting using the indicated antibodies. G , H Control and MYC overexpressing (MYC OE) ONS76 ( G ) or UW228.3 ( H ) cells were lysed. Levels of EIF4EBP1 mRNA were determined by qRT-PCR. Levels of 4EBP1 and MYC proteins were determined by immunoblots using the indicated antibodies. Data obtained by qRT-PCR represent the mean of three independent replicates ± SD and the fold change in expression was normalized to the control. Significance was calculated using an unpaired and two-tailed parametric t test (*** p < 0.001, **** p < 0.0001).

Article Snippet: Cells were transfected with 125 ng of the EIF4EBP1 promoter Firefly luciferase plasmid (wild type or mutants), 2 ng of Renilla luciferase expressing pRL SV40 plasmid (E2231, Promega; Madison, Wisconsin; USA), as internal control, and 25 ng, 50 ng or 100 ng of MYC expressing pcDNA3.3 MYC plasmid (kindly provided by Dr. Nan Qin, Düsseldorf, Germany), completed to 500 ng total DNA with pcDNA3.1 plasmid (V79020, Thermo Fisher Scientific) using CalFectin TM Cell Transfection Reagent (SL100478, SignaGen Laboratories, Frederick, MD; USA) according to the manufacturer’s guidelines.

Techniques: ChIP-sequencing, Luciferase, Construct, Binding Assay, Transfection, Mutagenesis, Plasmid Preparation, Control, Reporter Assay, Activity Assay, Standard Deviation, Two Tailed Test, Western Blot, Expressing, Negative Control, Incubation, Quantitative RT-PCR